MeSH tree: D12.776.124.400
A Novo Nordisk-designed trial, conducted at 68 international hospitals, specialist clinics, and medical centers with investigators from University of Texas Southwestern Medical Center and other institutions, reports greater ...
A multicenter collaboration of Danish researchers reports that once-weekly semaglutide for 30 weeks lowered blood sugar levels and body weight and improved physical quality of life in antipsychotic-treated adults with schizophrenia ...
Why do health stories about food and cancer grab so much attention? Because they offer an enticing promise: that a single item on your plate, or even a sudden change in what you crave, might hold the key to spotting disease ...
Sep 8, 2025
0
14
Eli Lilly says its new once-daily pill, orforglipron, helped people lose significant weight and lower blood sugar in a late-stage clinical trial.
Aug 27, 2025
0
39
Treatment with exagamglogene autotemcel (exa-cel) led to robust and sustained improvements in quality of life for patients with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia, according to two ...
Aug 27, 2025
0
22
Hemoglobin, long celebrated for ferrying oxygen in red blood cells, has now been revealed to play an overlooked—and potentially game-changing—antioxidant role in the brain.
Aug 21, 2025
0
53
Jeffrey Carson spent more than a decade persuading hospitals that fewer, resource-saving blood transfusions work just as well as more frequent transfusions for most patients. More recently, the Rutgers internist finished ...
Aug 21, 2025
0
23
Researchers from the Global Center for Asian Women's Health (GloW) and the Department of Obstetrics and Gynecology at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) have found that selected ...
Aug 19, 2025
0
31
A new study from Loughborough University has explored how gender-affirming hormone therapy (GAHT) affects the athletic performance of transgender women athletes.
Aug 18, 2025
0
32
A Phase III, international, randomized clinical trial assessed the safety and efficacy of canagliflozin for the treatment of type 2 diabetes mellitus (T2DM) in children and adolescents.
Aug 4, 2025
0
17
